Vitamin D3 induces pro-LL-37 expression in myeloid precursors from patients with severe congenital neutropenia

Journal of Leukocyte Biology

Volumn 84, Issue 5, 2008, Pages 1279-1286

  Karlsson, Jenny ^a   Carlsson, Göran ^b   Larne, Olivia ^a   Andersson, Mats ^a   Pütsep, Katrin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1.25(OH)2D3; All trans retinoic acid; hCAP18; Kostmann syndrome

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CCAAT ENHANCER BINDING PROTEIN EPSILON; COLECALCIFEROL; CYCLIC AMP; MESSENGER RNA; RETINOIC ACID; ANTIMICROBIAL CATIONIC PEPTIDE; CALCITRIOL; CATHELICIDIN ANTIMICROBIAL PEPTIDE;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE MUTATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INNATE IMMUNITY; MYELOID PROGENITOR CELL; NEUTROPENIA; NEUTROPHIL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; CELL DIFFERENTIATION; CHILD; GENETIC TRANSCRIPTION; GENETICS; LYMPHATIC LEUKEMIA; PHYSIOLOGY; REFERENCE VALUE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIBLING;

BACTERIA (MICROORGANISMS); HUMAN HERPESVIRUS 4;

ANTIMICROBIAL CATIONIC PEPTIDES; CALCITRIOL; CELL DIFFERENTIATION; CHILD; CHOLECALCIFEROL; HUMANS; NEUTROPENIA; NEUTROPHILS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIBLINGS; TRANSCRIPTION, GENETIC; TRETINOIN;

EID: 55549129604     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0607437     Document Type: Article

References (48)

1. Kostmann, R. (1956) Infantile genetic agranulocytosis; agranulocytosis infantalis hereditaria. Acta Paediatr. Suppl. 105, 45, 1-78.
2. Dale, D. C., Cottle, T. E., Fier, C. J., Bolyard, A. A., Bonilla, M. A., Boxer, L. A., Cham, B., Freedman, M. H., Kannourakis, G., Kinsey, S. E., Davis, R., Scarlata, D., Schwinzer, B., Zeidler, C., Welte, K. (2003) Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am. J. Hematol. 72, 82-93.
3. Dale, D. C., Person, R. E., Bolyard, A. A., Aprikyan, A. G., Bos, C., Bonilla, M. A., Boxer, L. A., Kannourakis, G., Zeidler, C., Welte, K., Benson, K. F., Horwitz, M. (2000) Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96, 2317-2322.
4. Klein, C., Grudzien, M., Appaswamy, G., Germeshausen, M., Sandrock, I., Schaffer, A. A., Rathinam, C., Boztug, K., Schwinzer, B., Rezaei, N., Bohn, G., Melin, M., Carlsson, G., Fadeel, B., Dahl, N., Palmblad, J., Henter, J. I., Zeidler, C., Grimbacher, B., Welte, K. (2007) HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat. Genet. 39, 86-92.
5. Karlsson, J., Carlsson, G., Ramme, K. G., Hagglund, H., Fadeel, B., Nordenskjold, M., Henter, J. I., Palmblad, J., Putsep, K., Andersson, M. (2007) Low plasma levels of the protein pro-LL-37 as an early indication of severe disease in patients with chronic neutropenia. Br. J. Haematol. 137, 166-169.
6. Defraia, E., Marinelli, A. (2001) Oral manifestations of congenital neutropenia or Kostmann syndrome. J. Clin. Pediatr. Dent. 26, 99-102.
7. Carlsson, G., Wahlin, Y. B., Johansson, A., Olsson, A., Eriksson, T., Claesson, R., Hanstrom, L., Henter, J. I. (2006) Periodontal disease in patients from the original Kostmann family with severe congenital neutropenia. J. Periodontol. 77, 744-751.
8. Carlsson, G., Fasth, A. (2001) Infantile genetic agranulocytosis, morbus Kostmann: presentation of six cases from the original "Kostmann family" and a review. Acta Paediatr. 90, 757-764.
9. Putsep, K., Carlsson, G., Boman, H. G., Andersson, M. (2002) Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 360, 1144-1149.
10. Andersson, M., Karlsson, J., Carlsson, G., Putsep, K. (2007) Expression of granule-associated proteins in neutrophils from patients with severe congenital neutropenia. Blood 110, 2772-2773.
11. Boman, H. G. (2000) Innate immunity and the normal microflora. Immunol. Rev. 173, 5-16.
12. Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., Gudmundsson, G. H. (1995) FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc. Natl. Acad. Sci. USA 92, 195-199.
13. Heilborn, J. D., Nilsson, M. F., Kratz, G., Weber, G., Sorensen, O., Borregaard, N., Stahle-Backdahl, M. (2003) The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120, 379-389.
14. Chromek, M., Slamova, Z., Bergman, P., Kovacs, L., Podracka, L., Ehren, I., Hokfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B., Brauner, A. (2006) The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat. Med. 12, 636-641.
15. De Yang, Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., Chertov, O. (2000) LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J. Exp. Med. 192, 1069-1074.
16. Nagaoka, I., Tamura, H., Hirata, M. (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7. J. Immunol. 176, 3044-3052.
17. Radomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T., Tenen, D. G. (1998) CCAAT/enhancer binding protein α is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18, 4301-4314.
18. Anderson, K. L., Smith, K. A., Perkin, H., Hermanson, G., Anderson, C. G., Jolly, D. J., Maki, R. A., Torbett, B. E. (1999) PU.1 and the granulocyte- and macrophage colony-stimulating factor receptors play distinct roles in late-stage myeloid cell differentiation. Blood 94, 2310-2318.
19. Cowland, J. B., Borregaard, N. (1999) The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66, 989-995.
20. Lekstrom-Himes, J. A., Dorman, S. E., Kopar, P., Holland, S. M., Gallin, J. I. (1999) Neutrophil-specific granule deficiency results from a novel mutation with loss of function of the transcription factor CCAAT/enhancer binding protein ε. J. Exp. Med. 189, 1847-1852.
21. Wang, T. T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., White, J. H. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 173, 2909-2912.
22. Gombart, A. F., Borregaard, N., Koeffler, H. P. (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J. 19, 1067-1077.
23. DeLuca, H. F. (2004) Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 80, 1689S-1696S.
24. Meier, C., Woitge, H. W., Witte, K., Lemmer, B., Seibel, M. J. (2004) Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J. Bone Miner. Res. 19, 1221-1230.
25. Yakisan, E., Schirg, E., Zeidler, C., Bishop, N. J., Reiter, A., Hirt, A., Riehm, H., Welte, K. (1997) High incidence of significant bone loss in patients with severe congenital neutropenia (Kostmann's syndrome). J. Pediatr. 131, 592-597.
26. Weber, G., Heilborn, J. D., Chamorro Jimenez, C. I., Hammarsjo, A., Torma, H., Stahle, M. (2005) Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 124, 1080-1082.
27. Borregaard, N., Sehested, M., Nielsen, B. S., Sengelov, H., Kjeldsen, L. (1995) Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 85, 812-817.
28. Cowland, J. B., Borregaard, N. (1999) Isolation of neutrophil precursors from bone marrow for biochemical and transcriptional analysis. J. Immunol. Methods 232, 191-200.
29. Elghetany, M. T. (2002) Surface antigen changes during normal neutrophilic development: a critical review. Blood Cells Mol. Dis. 28, 260-274.
30. Orfao, A., Ortuno, F., de Santiago, M., Lopez, A., San Miguel, J. (2004) Immunophenotyping of acute leukemias and myelodysplastic syndromes. Cytometry A 58, 62-71.
31. Van Lochem, E. G., van der Velden, V. H., Wind, H. K., te Marvelde, J. G., Westerdaal, N. A., van Dongen, J. J. (2004) Immunophenotypic differentiation patterns of normal hematopoiesis in human bone marrow: reference patterns for age-related changes and disease-induced shifts. Cytometry B Clin. Cytom. 60, 1-13.
32. Agerberth, B., Charo, J., Werr, J., Olsson, B., Idali, F., Lindbom, L., Kiessling, R., Jornvall, H., Wigzell, H., Gudmundsson, G. H. (2000) The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 96, 3086-3093.
33. Raff, T., van der Giet, M., Endemann, D., Wiederholt, T., Paul, M. (1997) Design and testing of β-actin primers for RT-PCR that do not co-amplify processed pseudogenes. Biotechniques 23, 456-460.
34. Sorensen, O., Arnljots, K., Cowland, J. B., Bainton, D. F., Borregaard, N. (1997) The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 90, 2796-2803.
35. Stoffels, K., Overbergh, L., Giulietti, A., Verlinden, L., Bouillon, R., Mathieu, C. (2006) Immune regulation of 25-hydroxyvitamin-D3-1α- hydroxylase in human monocytes. J. Bone Miner. Res. 21, 37-47.
36. Friedman, A. D. (2007) Transcriptional control of granulocyte and monocyte development. Oncogene 26, 6816-6828.
37. An, L. L., Ma, X. T., Yang, Y. H., Lin, Y. M., Song, Y. H., Wu, K. F. (2005) Marked reduction of LL-37/hCAP-18, an antimicrobial peptide, in patients with acute myeloid leukemia. Int. J. Hematol. 81, 45-47.
38. Elloumi, H. Z., Holland, S. M. (2008) Complex regulation of human cathelicidin gene expression: novel splice variants and 5′UTR negative regulatory element. Mol. Immunol. 45, 204-217.
39. Gray, T. K., Millington, D. S., Maltby, D. A., Williams, M. E., Cohen, M. S., Dodd, R. C. (1985) Phagocytic cells synthesize 19-nor-10-keto-25- hydroxyvitamin D3, a metabolite that may induce differentiation of the human monoblastic cell line U937. Proc. Natl. Acad. Sci. USA 82, 8218-8221.
40. Ganz, T., Metcalf, J. A., Gallin, J. I., Boxer, L. A., Lehrer, R. I. (1988) Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J. Clin. Invest. 82, 552-556.
41. Person, R. E., Li, F. Q., Duan, Z., Benson, K. F., Wechsler, J., Papadaki, H. A., Eliopoulos, G., Kaufman, C., Bertolone, S. J., Nakamoto, B., Papayannopoulou, T., Grimes, H. L., Horwitz, M. (2003) Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat. Genet. 34, 308-312.
42. Zarebski, A., Velu, C. S., Baktula, A. M., Bourdeau, T., Horman, S. R., Basu, S., Bertolone, S. J., Horwitz, M., Hildeman, D. A., Trent, J. O., Grimes, H. L. (2008) Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. Immunity 28, 370-380.
43. Khanna-Gupta, A., Sun, H., Zibello, T., Lee, H. M., Dahl, R., Boxer, L. A., Berliner, N. (2007) Growth factor independence-1 (Gfi-1) plays a role in mediating specific granule deficiency (SGD) in a patient lacking a gene-inactivating mutation in the C/EBPε gene. Blood 109, 4181-4190.
44. Nagaoka, I., Hirata, M., Sugimoto, K., Tsutsumi-Ishii, Y., Someya, A., Saionji, K., Igari, J. (1998) Evaluation of the expression of human CAP18 gene during neutrophil maturation in the bone marrow. J. Leukoc. Biol. 64, 845-852.
45. Bastie, J. N., Balitrand, N., Guidez, F., Guillemot, I., Larghero, J., Calabresse, C., Chomienne, C., Delva, L. (2004) 1 α,25-Dihydroxyvitamin D3 transrepresses retinoic acid transcriptional activity via vitamin D receptor in myeloid cells. Mol. Endocrinol. 18, 2685-2699.
46. Nakamura, K., Takahashi, T., Sasaki, Y., Tsuyuoka, R., Okuno, Y., Kurino, M., Ohmori, K., Iho, S., Nakao, K. (1996) 1,25-Dihydroxyvitamin D3 differentiates normal neutrophilic promyelocytes to monocytes/macrophages in vitro. Blood 87, 2693-2701.
47. Liu, P. T., Stenger, S., Li, H., Wenzel, L., Tan, B. H., Krutzik, S. R., Ochoa, M. T., Schauber, J., Wu, K., Meinken, C., Kamen, D. L., Wagner, M., Bals, R., Steinmeyer, A., Zugel, U., Gaoo, R. L., Eisenberg, D., Hewison, M., Hollis, B. W., Adams, J. S., Bloom, B. R., Modlin, R. L. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311, 1770-1773.
48. Zhang, P., Nelson, E., Radomska, H. S., Iwasaki-Arai, J., Akashi, K., Friedman, A. D., Tenen, D. G. (2002) Induction of granulocytic differentiation by 2 pathways. Blood 99, 4406-4412.